Chemical Compound Review:
Rubomycin (7S,9R)-7-[(2S,4S,5S,6S)-4- amino-5-hydroxy...
Synonyms:
Cerubidine, Daunomycin, Rubidomycin, Daunoblastin, daunorubicin, ...
- Verapamil restoration of daunorubicin responsiveness in daunorubicin-resistant Ehrlich ascites carcinoma. Slater, L.M., Murray, S.L., Wetzel, M.W., Wisdom, R.M., DuVall, E.M. J. Clin. Invest. (1982)
- Reversal of daunorubicin resistance in P388/ADR cells by itraconazole. Gupta, S., Kim, J., Gollapudi, S. J. Clin. Invest. (1991)
- Liposomal daunorubicin treatment of HIV-associated Kaposi's sarcoma. Presant, C.A., Scolaro, M., Kennedy, P., Blayney, D.W., Flanagan, B., Lisak, J., Presant, J. Lancet (1993)
- The place of bone-marrow transplantation in acute myelogenous leukaemia. Powles, R.L., Morgenstern, G., Clink, H.M., Hedley, D., Bandini, G., Lumley, H., Watson, J.G., Lawson, D., Spence, D., Barrett, A., Jameson, B., Lawler, S., Kay, H.E., McElwain, T.J. Lancet (1980)
- Lipid peroxidation and antioxidant defense mechanisms in rat renal tissue after daunorubicin administration. Dioudis, C., Grekas, D., Papageorgiou, G., Iliadis, S., Botsoglou, N., Zilidis, C., Tourkantonis, A., Trakatellis, A. Renal failure. (1996)
- All-trans-retinoic acid in acute promyelocytic leukemia. Tallman, M.S., Andersen, J.W., Schiffer, C.A., Appelbaum, F.R., Feusner, J.H., Ogden, A., Shepherd, L., Willman, C., Bloomfield, C.D., Rowe, J.M., Wiernik, P.H. N. Engl. J. Med. (1997)
- Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. Zittoun, R.A., Mandelli, F., Willemze, R., de Witte, T., Labar, B., Resegotti, L., Leoni, F., Damasio, E., Visani, G., Papa, G. N. Engl. J. Med. (1995)
- TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Wang, C.Y., Mayo, M.W., Baldwin, A.S. Science (1996)
- Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B. Campbell, K.J., Rocha, S., Perkins, N.D. Mol. Cell (2004)
- Gene amplification-associated cytogenetic aberrations and protein changes in vincristine-resistant Chinese hamster, mouse, and human cells. Meyers, M.B., Spengler, B.A., Chang, T.D., Melera, P.W., Biedler, J.L. J. Cell Biol. (1985)
- Intensive chemotherapy for acute myelogenous leukemia. Gale, R.P., Foon, K.A., Cline, M.J., Zighelboim, J. Ann. Intern. Med. (1981)
- A bacterial analog of the mdr gene of mammalian tumor cells is present in Streptomyces peucetius, the producer of daunorubicin and doxorubicin. Guilfoile, P.G., Hutchinson, C.R. Proc. Natl. Acad. Sci. U.S.A. (1991)
- Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study. List, A.F., Kopecky, K.J., Willman, C.L., Head, D.R., Persons, D.L., Slovak, M.L., Dorr, R., Karanes, C., Hynes, H.E., Doroshow, J.H., Shurafa, M., Appelbaum, F.R. Blood (2001)
- Results of consecutive trials for children newly diagnosed with acute myeloid leukemia from the Australian and New Zealand Children's Cancer Study Group. O'Brien, T.A., Russell, S.J., Vowels, M.R., Oswald, C.M., Tiedemann, K., Shaw, P.J., Lockwood, L., Teague, L., Rice, M., Marshall, G.M. Blood (2002)
- Stimulus-dependent synergism of the antiapoptotic tumor necrosis factor receptor-associated factor 2 (TRAF2) and nuclear factor kappaB pathways. Lee, S.Y., Kaufman, D.R., Mora, A.L., Santana, A., Boothby, M., Choi, Y. J. Exp. Med. (1998)
- Role of daunosamine and hydroxyacetyl side chain in reaction with iron and lipid peroxidation by anthracyclines. Gianni, L., Viganò, L., Lanzi, C., Niggeler, M., Malatesta, V. J. Natl. Cancer Inst. (1988)
- Reversal of the multidrug-resistant phenotype of Chinese hamster ovary cells by L-histidinol. Warrington, R.C., Fang, W.D. J. Natl. Cancer Inst. (1989)
- Increase in nonspecific adsorptive endocytosis in anthracycline- and vinca alkaloid-resistant Ehrlich ascites tumor cell lines. Sehested, M., Skovsgaard, T., van Deurs, B., Winther-Nielsen, H. J. Natl. Cancer Inst. (1987)
- Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells. Evers, R., Zaman, G.J., van Deemter, L., Jansen, H., Calafat, J., Oomen, L.C., Oude Elferink, R.P., Borst, P., Schinkel, A.H. J. Clin. Invest. (1996)
- Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro. Slater, L.M., Sweet, P., Stupecky, M., Gupta, S. J. Clin. Invest. (1986)
- Cytotoxicity of adriamycin and daunorubicin for normal and leukemia progenitor cells of man. Buick, R.N., Messner, H.A., Till, J.E., McCulloch, E.A. J. Natl. Cancer Inst. (1979)
- Circumvention of multiple-drug resistance in human cancer cells by thioridazine, trifluoperazine, and chlorpromazine. Akiyama, S., Shiraishi, N., Kuratomi, Y., Nakagawa, M., Kuwano, M. J. Natl. Cancer Inst. (1986)
- Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833. Beketic-Oreskovic, L., Durán, G.E., Chen, G., Dumontet, C., Sikic, B.I. J. Natl. Cancer Inst. (1995)
- Increased therapeutic index of antineoplastic drugs in combination with intracellular histamine antagonists. Brandes, L.J., LaBella, F.S., Warrington, R.C. J. Natl. Cancer Inst. (1991)
- An anti-alpha-fetoprotein antibody-daunorubicin conjugate with a novel poly-L-glutamic acid derivative as intermediate drug carrier. Tsukada, Y., Kato, Y., Umemoto, N., Takeda, Y., Hara, T., Hirai, H. J. Natl. Cancer Inst. (1984)
- Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Zaman, G.J., Lankelma, J., van Tellingen, O., Beijnen, J., Dekker, H., Paulusma, C., Oude Elferink, R.P., Baas, F., Borst, P. Proc. Natl. Acad. Sci. U.S.A. (1995)
- Protein kinase Czeta mediated Raf-1/extracellular-regulated kinase activation by daunorubicin. Mas, V.M., Hernandez, H., Plo, I., Bezombes, C., Maestre, N., Quillet-Mary, A., Filomenko, R., Demur, C., Jaffrézou, J.P., Laurent, G. Blood (2003)
- Aromatic hydrocarbon receptor (AhR).AhR nuclear translocator- and p53-mediated induction of the murine multidrug resistance mdr1 gene by 3-methylcholanthrene and benzo(a)pyrene in hepatoma cells. Mathieu, M.C., Lapierre, I., Brault, K., Raymond, M. J. Biol. Chem. (2001)
- The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2). Litman, T., Brangi, M., Hudson, E., Fetsch, P., Abati, A., Ross, D.D., Miyake, K., Resau, J.H., Bates, S.E. J. Cell. Sci. (2000)
- VX-710 (biricodar) increases drug retention and enhances chemosensitivity in resistant cells overexpressing P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein. Minderman, H., O'Loughlin, K.L., Pendyala, L., Baer, M.R. Clin. Cancer Res. (2004)
- Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B. Stone, R.M., Berg, D.T., George, S.L., Dodge, R.K., Paciucci, P.A., Schulman, P., Lee, E.J., Moore, J.O., Powell, B.L., Schiffer, C.A. N. Engl. J. Med. (1995)
- Measurement of cremophor EL following taxol: plasma levels sufficient to reverse drug exclusion mediated by the multidrug-resistant phenotype. Webster, L., Linsenmeyer, M., Millward, M., Morton, C., Bishop, J., Woodcock, D. J. Natl. Cancer Inst. (1993)
- Effect of tamoxifen on cell lines displaying the multidrug-resistant phenotype. Berman, E., Adams, M., Duigou-Osterndorf, R., Godfrey, L., Clarkson, B., Andreeff, M. Blood (1991)
- Correlation of drug sensitivity in vitro with clinical responses in childhood acute myeloid leukemia. Dow, L.W., Dahl, G.V., Kalwinsky, D.K., Mirro, J., Nash, M.B., Roberson, P.K. Blood (1986)
- Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia. List, A.F., Spier, C., Greer, J., Wolff, S., Hutter, J., Dorr, R., Salmon, S., Futscher, B., Baier, M., Dalton, W. J. Clin. Oncol. (1993)